QTc prolongations as a result of drug interactions of CD4/6 inhibitors

Aleksandra Grela-Wojewoda; Mirosława Puskulluoglu; Joanna Lompart; Marek Ziobro; Ewa Konduracka

doi:10.5603/NJO.a2022.0032

Vol 72, No 4 (2022)

Pictures in Oncology

Published online: 2022-05-25

View PDF

Download PDF file

Get Citation

QTc prolongations as a result of drug interactions of CD4/6 inhibitors

Aleksandra Grela-Wojewoda¹

, Mirosława Puskulluoglu¹, Joanna Lompart¹, Marek Ziobro¹, Ewa Konduracka²

DOI: 10.5603/NJO.a2022.0032

Nowotwory. Journal of Oncology 2022;72(4):258.

Affiliations

Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland
Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland

Vol 72, No 4 (2022)

Pictures in oncology

Published online: 2022-05-25

Abstract

Not available

Abstract

Not available

Full Text:

View PDF

Download PDF file

Get Citation

About this article

Title

QTc prolongations as a result of drug interactions of CD4/6 inhibitors

Journal

Nowotwory. Journal of Oncology

Issue

Vol 72, No 4 (2022)

Article type

Pictures in Oncology

Pages

258

Published online

2022-05-25

Page views

3905

Article views/downloads

335

DOI

10.5603/NJO.a2022.0032

Bibliographic record

Nowotwory. Journal of Oncology 2022;72(4):258.

Authors

Aleksandra Grela-Wojewoda
Mirosława Puskulluoglu
Joanna Lompart
Marek Ziobro
Ewa Konduracka

References (2)

Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, et al. Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. Int J Mol Sci. 2022; 23(5): 2815.
CrossRefPubMed
Rascon K, Flajc G, De Angelis C, et al. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother. 2019; 53(5): 501–509.
CrossRefPubMed